Back to newsTrevi Therapeutics, Inc. <TRVI.O>: Raymond James Raises Target Price to $40 From $27TTRVI•2026-08-07Related NewsEExpensify jumps after Q2 profit beatEXFY•2026-08-07AAmetek declares quarterly dividend of $0.34 per shareAME•2026-08-07IInnoviz Technologies announces annual shareholder meetingINVZ•2026-08-07YYXT.com schedules first-half earnings release and conference callYXT•2026-08-07DDoximity shares surge after first-quarter revenue beats estimatesDOCS•2026-08-07
TRVI•TRVI•TRVI•TRVI•
